Voyager Therapeutics (VYGR) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Voyager Therapeutics (VYGR) over the last 10 years, with Q4 2024 value amounting to $16.0 million.
- Voyager Therapeutics' Accumulated Depreciation & Amortization rose 611.78% to $16.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $16.0 million, marking a year-over-year increase of 611.78%. This contributed to the annual value of $16.0 million for FY2024, which is 611.78% up from last year.
- As of Q4 2024, Voyager Therapeutics' Accumulated Depreciation & Amortization stood at $16.0 million, which was up 611.78% from $15.0 million recorded in Q4 2023.
- In the past 5 years, Voyager Therapeutics' Accumulated Depreciation & Amortization registered a high of $17.2 million during Q4 2022, and its lowest value of $11.6 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $15.9 million (2021), whereas its average is $15.1 million.
- Per our database at Business Quant, Voyager Therapeutics' Accumulated Depreciation & Amortization surged by 5110.36% in 2020 and then plummeted by 1260.53% in 2023.
- Voyager Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $11.6 million in 2020, then skyrocketed by 37.54% to $15.9 million in 2021, then grew by 8.13% to $17.2 million in 2022, then decreased by 12.61% to $15.0 million in 2023, then rose by 6.12% to $16.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $16.0 million in Q4 2024, compared to $15.0 million in Q4 2023 and $17.2 million in Q4 2022.